Frontlight ResearchEarly access
WithdrawnPhase 4
Comparing Diuretic Strategies in Hospitalized Heart Failure
Key facts
- Who runs it
- Stanford University
- Where
- Palo Alto, United StatesSee the site
- Trial code
- Status
- Withdrawn
- Phase
- Phase 4
- Started
- Jul 2023
- Ended
- Jun 2024
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Loop Diuretics vs. loop + thiazide diuretics
- Record updated
- 12 April 2023
- Why it stopped
- Due to administrative and logistical barriers this trial has been withdrawn.
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Any adult (age ≥18 years) admitted to the Heart Failure Service at Stanford Health Care with an indication for treatment with a diuretic
Who cannot take part
- admission to the intensive care unit or cardiac care units
- history of heart transplant
- allergy / intolerance to loop or thiazide diuretics
- admission serum sodium < 125 meq/L (from EPIC)
- admission serum potassium < 3.0 meq/L (from EPIC)
- maintenance dialysis on admission
- any mechanical circulatory support on admission
Where in United States
- Stanford Health CarePalo Alto, United States
About the trial
What the trial wants to find out
We will conduct a pragmatic randomized trial comparing whether using a combination of two types of diuretics (loop + thiazide) compared with using a single diuretic (loop only) will result in shorter hospital stays for patients hospitalized with heart failure.
The 2 groups in the trial
- Loop onlyExisting treatment, for comparison
Participants will receive a loop diuretic for up to the first 72 hours of hospitalization. The specific drug, dose and route are left to the treating providers.
Treatment: Loop Diuretics vs. loop + thiazide diuretics
- Loop + ThiazideExisting treatment, for comparison
Participants will receive a loop+thiazide diuretic for up to the first 72 hours of hospitalization. The specific drugs, doses and routes are left to the treating providers.
Treatment: Loop Diuretics vs. loop + thiazide diuretics
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Creating a Platform for Point-of-Care Pragmatic Clinical Trials: Comparing Diuretic Strategies in Heart Failure
- Record updated
- 12 April 2023